US Stock MarketDetailed Quotes

PATH UiPath

Watchlist

13.180
+0.050+0.38%

Close Dec 26 16:00 ET

13.190
+0.010+0.08%

Post 19:57 ET

7.24BMarket Cap-82.38P/E (TTM)

UiPath Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

UiPath Q3 2025 Earnings Date

Currency：USDDec 5, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	347.72M	354.65M	+6.93M
Beat Est.	+6.69%	+8.82%	+1.99%
EPS	-0.09	-0.02	+0.07
Beat Est.	-53.42%	+66.67%	+78.24%

Analyst Rating

Hold

Dec 12, 2024

UiPath Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 17 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2026/Q1	-- / 367.292M	--
--	2025/Q4	-- / 425.446M	--
Dec 5, 2024	2025/Q3	354.653M / 347.720M	--
Sep 5, 2024	2025/Q2	316.253M / 303.740M	--
May 29, 2024	2025/Q1	335.112M / 333.008M	--

DatePeriodRevenue/EstimateEarnings Call

--2026/Q1-- / 367.292M--

--2025/Q4-- / 425.446M--

Dec 5, 20242025/Q3354.653M / 347.720M--

Sep 5, 20242025/Q2316.253M / 303.740M--

May 29, 20242025/Q1335.112M / 333.008M--

Unlock Free Earnings Estimates

Open Account

UiPath Earnings Reports

UiPath | 10-Q: Q3 2025 Earnings Report

Dec 9 13:16 ET

UiPath | 8-K: UiPath Reports Third Quarter Fiscal 2025 Financial Results

Dec 5 16:21 ET

UiPath | 10-Q: Q2 2025 Earnings Report

Sep 6 17:15 ET

UiPath | 8-K: UiPath Reports Second Quarter Fiscal 2025 Financial Results

Sep 5 16:28 ET

Trending US Stocks

Symbol Mini Chart % Chg

Collegium Pharmaceutical

Unlock the Full List

Analysis

Analyst Rating

Updated: Dec 12, 2024

Hold

Buy
11.11%
Hold
83.33%
Sell
5.56%

Price Target

No Data

Artificial Intelligence

Intraday-0.34%